DIABECOV-CM (Q6844160): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item)
(‎Set a claim value: summary (P836): COVID-19 e Diabetes. Estudo integrado do papel da dipeptidil peptidase 4 na infeção pelo SARSCoV-2.)
 
(2 intermediate revisions by the same user not shown)
Property / budget
610,000.0 Euro
Amount610,000.0 Euro
UnitEuro
 
Property / budget: 610,000.0 Euro / rank
Preferred rank
 
Property / EU contribution
305,000.0 Euro
Amount305,000.0 Euro
UnitEuro
 
Property / EU contribution: 305,000.0 Euro / rank
Preferred rank
 
Property / co-financing rate
50.0 percent
Amount50.0 percent
Unitpercent
 
Property / co-financing rate: 50.0 percent / rank
Normal rank
 
Property / summary: COVID-19 and Diabetes. Integrated study of the role of dipeptidyl peptidase 4 in SARSCoV-2 infection. (English) / qualifier
 
readability score: 0.0069415542950836
Amount0.0069415542950836
Unit1
Property / summaryProperty / summary
COVID-19 e Diabetes. Estudo integrado do papel da dipeptidil peptidase 4 na infeção por SARSCoV-2. (Portuguese)
COVID-19 e Diabetes. Estudo integrado do papel da dipeptidil peptidase 4 na infeção pelo SARSCoV-2. (Portuguese)
Property / date of last update
6 July 2023
Timestamp+2023-07-06T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / date of last update: 6 July 2023 / rank
Normal rank
 
Property / budget
 
610,000.0 Euro
Amount610,000.0 Euro
UnitEuro
Property / budget: 610,000.0 Euro / rank
 
Preferred rank
Property / EU contribution
 
610,000.0 Euro
Amount610,000.0 Euro
UnitEuro
Property / EU contribution: 610,000.0 Euro / rank
 
Preferred rank
Property / co-financing rate
 
100.0 percent
Amount100.0 percent
Unitpercent
Property / co-financing rate: 100.0 percent / rank
 
Normal rank
Property / date of last update
 
21 December 2023
Timestamp+2023-12-21T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / date of last update: 21 December 2023 / rank
 
Normal rank

Latest revision as of 23:43, 12 October 2024

Project DGUI/20/11/001-21/08/2 in Spain
Language Label Description Also known as
English
DIABECOV-CM
Project DGUI/20/11/001-21/08/2 in Spain

    Statements

    0 references
    0 references
    610,000.0 Euro
    0 references
    610,000.0 Euro
    0 references
    100.0 percent
    0 references
    1 February 2020
    0 references
    30 December 2022
    0 references
    UNIVERSIDAD DE ALCALA DE HENARES
    0 references
    0 references

    40°28'54.62"N, 3°21'52.20"W
    0 references
    Covid-19 y Diabetes. Estudio integrado del papel de la Dipeptidil peptidasa 4 en la infección por SARSCoV-2. (Spanish)
    0 references
    COVID-19 и диабет. Интегрирано проучване на ролята на дипептидил пептидаза 4 при инфекция със SARSCoV-2. (Bulgarian)
    0 references
    COVID-19 a diabetes. Integrovaná studie role dipeptidylpeptidázy 4 u infekce SARSCoV-2. (Czech)
    0 references
    Covid-19 og diabetes. Integreret undersøgelse af dipeptidylpeptidase 4's rolle i SARSCoV-2-infektion. (Danish)
    0 references
    COVID-19 und Diabetes. Integrierte Studie der Rolle der Dipeptidylpeptidase 4 bei der SARSCoV-2-Infektion. (German)
    0 references
    COVID-19 και διαβήτης. Ολοκληρωμένη μελέτη του ρόλου της διπεπτιδυλοπεπτιδάσης 4 στη λοίμωξη SARSCoV-2. (Greek)
    0 references
    COVID-19 and Diabetes. Integrated study of the role of dipeptidyl peptidase 4 in SARSCoV-2 infection. (English)
    0.0069415542950836
    0 references
    COVID-19 ja diabeet. Integreeritud uuring dipeptidüülpeptidaasi 4 rolli kohta SARSCoV-2 infektsioonis. (Estonian)
    0 references
    Covid-19 ja diabetes. Integroitu tutkimus dipeptidyylipeptidaasi 4:n roolista SARSCoV-2-infektiossa. (Finnish)
    0 references
    COVID-19 et diabète. Étude intégrée du rôle de la dipeptidyl peptidase 4 dans l’infection SARSCoV-2. (French)
    0 references
    COVID-19 agus Diaibéiteas. Staidéar comhtháite ar ról dipeptidyl peptidase 4 in ionfhabhtú SARSCoV-2. (Irish)
    0 references
    COVID-19 i dijabetes. Integrirano ispitivanje uloge dipeptidil peptidaze 4 u infekciji virusom SARSCoV-2. (Croatian)
    0 references
    Covid19 és diabétesz. A dipeptidil-peptidáz 4 szerepének integrált vizsgálata a SARSCoV-2 fertőzésben. (Hungarian)
    0 references
    COVID-19 e diabete. Studio integrato del ruolo della dipeptidil peptidasi 4 nell'infezione da SARSCoV-2. (Italian)
    0 references
    COVID-19 ir diabetas. Integruotas dipeptidilpeptidazės 4 vaidmens gydant SARSCoV-2 infekciją tyrimas. (Lithuanian)
    0 references
    Covid-19 un diabēts. Integrēts pētījums par dipeptidilpeptidāzes 4 lomu SARSCoV-2 infekcijas gadījumā. (Latvian)
    0 references
    COVID-19 u Dijabete. Studju integrat tar-rwol tad-dipeptidyl peptidase 4 fl-infezzjoni tas-SARSCoV-2. (Maltese)
    0 references
    COVID-19 en diabetes. Geïntegreerd onderzoek naar de rol van dipeptidylpeptidase 4 bij SARSCoV-2-infectie. (Dutch)
    0 references
    COVID-19 e Diabetes. Estudo integrado do papel da dipeptidil peptidase 4 na infeção pelo SARSCoV-2. (Portuguese)
    0 references
    COVID-19 și diabetul. Studiu integrat privind rolul dipeptidil peptidazei 4 în infecția cu SARSCoV-2. (Romanian)
    0 references
    COVID-19 a diabetes. Integrovaná štúdia úlohy dipeptidylpeptidázy 4 pri infekcii SARSCoV-2. (Slovak)
    0 references
    COVID-19 in sladkorna bolezen. Integrirana študija vloge dipeptidil peptidaze 4 pri okužbi s SARSCoV-2. (Slovenian)
    0 references
    Covid-19 och diabetes. Integrerad studie av betydelsen av dipeptidylpeptidas 4 vid SARSCoV-2-infektion. (Swedish)
    0 references
    12 June 2023
    0 references
    Alcalá de Henares
    0 references
    21 December 2023
    0 references

    Identifiers

    DGUI/20/11/001-21/08/2
    0 references